IANS | 28 Mar, 2024
Leading venture capital firm Accel on Thursday announced eight
early-stage startups in India which are part of the third cohort of its
accelerator programme called ‘Atoms’.
The cohort receives up to
$500,000 in funding, access to perks worth more than $5 million from
Accel’s network partners, personalised mentorship, and the opportunity
to collaborate with a strong peer community of founders from past
cohorts and portfolio founders.
The 24 startups, which were part
of the two previous Atoms cohorts, have raised over $200 million in
funding since the launch of the programme, the VC firm said in a
statement.
“We believe we have found the next wave of disruptors
in AI and Industry 5.0, and the proof of this has been witnessing the
growth of each of these startups since joining the programme,” said
Prayank Swaroop, Partner at Accel.
“As part of Atoms 3.0, founders are also learning how to build that muscle for resilience and agility,” Swaroop added.
The
four AI startups that are part of Atoms 3.0 are: Tune AI, a GenAI stack
for enterprises; Skoob, a generative AI platform for reading; Meritic, a
storytelling co-pilot for financial planning and analysis; and
Arivihan, India's first AI-based, fully automated learning platform.
The
two industry 5.0 startups in this cohort are: Spintly, an IoT platform
for smart buildings; and Asets, a multidisciplinary CAD, simulation and
engineering design platform.
The two remaining startups from the cohort are in stealth mode.
Barath
Shankar Subramanian, Partner at Accel, said that the 6-month ‘Atoms
3.0’ journey is giving founders “insight into critical zero-to-1 areas
like hiring, getting your first 10 customers, or tuning your pitch for
investors”.
“Through one-on-one sessions with their domain
leaders, the founders also get clarity on how to action those learnings
and lay out their roadmap for each month,” Subramanian added.
Accel
has been the first partner to many of India’s most successful startups,
including Flipkart, Freshworks, Swiggy, Urban Company, Zetwerk and
Cure.fit.